{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T03:05:40Z","timestamp":1791947140730,"version":"4.3.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"The National Research Foundation of Korea","doi-asserted-by":"crossref","award":["NRF-2021R1A2C2005192"],"award-info":[{"award-number":["NRF-2021R1A2C2005192"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003725","name":"The National Research Foundation of Korea","doi-asserted-by":"crossref","award":["RS-2023-00209312"],"award-info":[{"award-number":["RS-2023-00209312"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>The aim of this study is to establish an <jats:italic>in vitro<\/jats:italic> co-culture system to model allograft rejection using kidney organoids system derived from human induced pluripotent stem cells (hiPSCs). We co-cultured kidney organoids derived from wild-type hiPSCs with HLA-mismatched peripheral blood mononuclear cells (PBMCs) from healthy controls (HC) for 24\u00a0h. To assess allogeneic rejection modeling, we measured the expression of HLA molecules, (HLA-ABC and HLA-DR), and evaluated cellular damage in the kidney organoids. Additionally, we analyzed the distribution of T cells and their subsets within the co-cultured PBMCs. The immunosuppressive effect of tacrolimus was also evaluated in this co-culture system. Transcriptomic analysis, conducted using RNA sequencing, identified molecules associated with allogeneic rejection. When kidney organoids were co-cultured with alloreactive PBMCs for 24\u00a0h, HLA-ABC and HLA-DR expression significantly increased in kidney organoid cells. Additionally, kidney organoids showed reduced cell viability and increased apoptosis compared to syngeneic controls, as assessed by flow cytometry and Annexin V\/PI staining. However, treatment with tacrolimus reduced HLA expression in a dose-dependent manner, highlighting the diminished alloimmune responses. Further analysis of PBMC subsets revealed shifts in T helper (TH) and cytotoxic T cell (TC) populations under allogeneic conditions, including increased effector TH and TC cells. Transcriptomic analysis through RNA sequencing identified 256 differentially expressed genes (DEGs), with notable immune-related pathways such as NF-kappa B and TNF signaling involved in allograft rejection. These results provide evidence that a co-culture system with allogeneic kidney organoids and PBMCs can potentially model transplant rejection in vitro.<\/jats:p>","DOI":"10.1007\/s00018-025-05867-7","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T04:43:07Z","timestamp":1756788187000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Modeling of kidney allograft rejection using hiPSC-derived kidney organoids and HLA-mismatched PBMCs: an in vitro co-culture system"],"prefix":"10.1007","volume":"82","author":[{"given":"Sun Woo","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianying","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Do Hyun","family":"Na","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanbi","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoo Jin","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunhye","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Jee","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0048-5717","authenticated-orcid":false,"given":"Byung Ha","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,2]]},"reference":[{"key":"5867_CR1","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1097\/00007890-200211270-00005","volume":"74","author":"HU Meier-Kriesche","year":"2002","unstructured":"Meier-Kriesche HU, Kaplan B (2002) Waiting time on dialysis as the strongest modifiable risk factor for renal transplant outcomes: a paired donor kidney analysis. Transplantation 74:1377\u20131381","journal-title":"Transplantation"},{"key":"5867_CR2","doi-asserted-by":"publisher","first-page":"497","DOI":"10.2215\/CJN.08670815","volume":"11","author":"N Goto","year":"2016","unstructured":"Goto N, Okada M, Yamamoto T, Tsujita M, Hiramitsu T, Narumi S, Katayama A, Kobayashi T, Uchida K, Watarai Y (2016) Association of dialysis duration with outcomes after transplantation in a Japanese cohort. Clin J Am Soc Nephrol 11:497\u2013504","journal-title":"Clin J Am Soc Nephrol"},{"key":"5867_CR3","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1111\/ajt.16883","volume":"22","author":"C Rampersad","year":"2022","unstructured":"Rampersad C, Balshaw R, Gibson IW, Ho J, Shaw J, Karpinski M, Goldberg A, Birk P, Rush DN, Nickerson PW et al (2022) The negative impact of T cell-mediated rejection on renal allograft survival in the modern era. Am J Transplant 22:761\u2013771","journal-title":"Am J Transplant"},{"key":"5867_CR4","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1111\/ajt.15860","volume":"20","author":"C Wiebe","year":"2020","unstructured":"Wiebe C, Rush DN, Gibson IW, Pochinco D, Birk PE, Goldberg A, Blydt-Hansen T, Karpinski M, Shaw J, Ho J et al (2020) Evidence for the alloimmune basis and prognostic significance of borderline T cell-mediated rejection. Am J Transplant 20:2499\u20132508","journal-title":"Am J Transplant"},{"key":"5867_CR5","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1056\/NEJMra2014530","volume":"385","author":"S Hariharan","year":"2021","unstructured":"Hariharan S, Israni AK, Danovitch G (2021) Long-term survival after kidney transplantation. N Engl J Med 385:729\u2013743","journal-title":"N Engl J Med"},{"key":"5867_CR6","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1056\/NEJMra033540","volume":"351","author":"PF Halloran","year":"2004","unstructured":"Halloran PF (2004) Immunosuppressive drugs for kidney transplantation. N Engl J Med 351:2715\u20132729","journal-title":"N Engl J Med"},{"key":"5867_CR7","doi-asserted-by":"publisher","first-page":"607953","DOI":"10.3389\/fimmu.2021.607953","volume":"12","author":"DM Peelen","year":"2021","unstructured":"Peelen DM, Hoogduijn MJ, Hesselink DA, Baan CC (2021) Advanced in vitro research models to study the role of endothelial cells in solid organ transplantation. Front Immunol 12:607953","journal-title":"Front Immunol"},{"key":"5867_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3390\/transplantology2040039","volume":"2","author":"N Wenzel","year":"2021","unstructured":"Wenzel N, Blasczyk R, Figueiredo C (2021) Animal models in allogenic solid organ transplantation. Transplantology 2:13","journal-title":"Transplantology"},{"key":"5867_CR9","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a015495","volume":"3","author":"AS Chong","year":"2013","unstructured":"Chong AS, Alegre ML, Miller ML, Fairchild RL (2013) Lessons and limits of mouse models. Cold Spring Harb Perspect Med 3:a015495","journal-title":"Cold Spring Harb Perspect Med"},{"key":"5867_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-27141-6","volume":"8","author":"KW Kim","year":"2018","unstructured":"Kim KW, Kim BM, Doh KC, Cho ML, Yang CW, Chung BH (2018) Clinical significance of CCR7(+)CD8(+) T cells in kidney transplant recipients with allograft rejection. Sci Rep 8:8827","journal-title":"Sci Rep"},{"key":"5867_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0172536","volume":"12","author":"BH Chung","year":"2017","unstructured":"Chung BH, Kim BM, Doh KC, Cho ML, Kim KW, Yang CW (2017) Protective effect of 1alpha,25-dihydroxyvitamin D3 on effector CD4+ T cell induced injury in human renal proximal tubular epithelial cells. PLoS One 12:e0172536","journal-title":"PLoS One"},{"key":"5867_CR12","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.tcb.2023.09.005","volume":"34","author":"E Dilmen","year":"2024","unstructured":"Dilmen E, Orhon I, Jansen J, Hoenderop JGJ (2024) Advancements in kidney organoids and tubuloids to study (dys)function. Trends Cell Biol 34:299\u2013311","journal-title":"Trends Cell Biol"},{"key":"5867_CR13","first-page":"153","volume":"10","author":"BS Freedman","year":"2015","unstructured":"Freedman BS (2015) Modeling kidney disease with iPS cells. Biomark Insights 10:153\u2013169","journal-title":"Biomark Insights"},{"key":"5867_CR14","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41576-019-0100-z","volume":"20","author":"RG Rowe","year":"2019","unstructured":"Rowe RG, Daley GQ (2019) Induced pluripotent stem cells in disease modelling and drug discovery. Nat Rev Genet 20:377\u2013388","journal-title":"Nat Rev Genet"},{"key":"5867_CR15","doi-asserted-by":"publisher","first-page":"114","DOI":"10.4252\/wjsc.v16.i2.114","volume":"16","author":"HY Long","year":"2024","unstructured":"Long HY, Qian ZP, Lan Q, Xu YJ, Da JJ, Yu FX, Zha Y (2024) Human pluripotent stem cell-derived kidney organoids: current progress and challenges. World J Stem Cells 16:114\u2013125","journal-title":"World J Stem Cells"},{"issue":"4","key":"5867_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/cells12040549","volume":"12","author":"BE Chambers","year":"2023","unstructured":"Chambers BE, Weaver NE, Wingert RA (2023) The \u201c3Ds\u201d of growing kidney organoids: advances in nephron development, disease modeling, and drug screening. Cells 12(4):549","journal-title":"Cells"},{"key":"5867_CR17","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.stem.2023.07.011","volume":"30","author":"R Nishinakamura","year":"2023","unstructured":"Nishinakamura R (2023) Advances and challenges toward developing kidney organoids for clinical applications. Cell Stem Cell 30:1017\u20131027","journal-title":"Cell Stem Cell"},{"key":"5867_CR18","doi-asserted-by":"publisher","first-page":"563981","DOI":"10.3389\/fphys.2020.563981","volume":"11","author":"R Romero-Guevara","year":"2020","unstructured":"Romero-Guevara R, Ioannides A, Xinaris C (2020) Kidney organoids as disease models: strengths, weaknesses and perspectives. Front Physiol 11:563981","journal-title":"Front Physiol"},{"key":"5867_CR19","doi-asserted-by":"publisher","first-page":"8715","DOI":"10.1038\/ncomms9715","volume":"6","author":"BS Freedman","year":"2015","unstructured":"Freedman BS, Brooks CR, Lam AQ, Fu H, Morizane R, Agrawal V, Saad AF, Li MK, Hughes MR, Werff RV et al (2015) Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids. Nat Commun 6:8715","journal-title":"Nat Commun"},{"issue":"3","key":"5867_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24033019","volume":"24","author":"SW Lim","year":"2023","unstructured":"Lim SW, Fang X, Cui S, Lee H, Shin YJ, Ko EJ, Lee KI, Lee JY, Chung BH, Yang CW (2023) CRISPR-Cas9-mediated correction of SLC12A3 gene mutation rescues the gitelman\u2019s disease phenotype in a patient-derived kidney organoid system. Int J Mol Sci 24(3):3019","journal-title":"Int J Mol Sci"},{"key":"5867_CR21","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12967-023-03992-0","volume":"21","author":"S Cui","year":"2023","unstructured":"Cui S, Fang X, Lee H, Shin YJ, Koh ES, Chung S, Park HS, Lim SW, Lee KI, Lee JY et al (2023) Modeling of Fabry disease nephropathy using patient derived human induced pluripotent stem cells and kidney organoid system. J Transl Med 21:138","journal-title":"J Transl Med"},{"key":"5867_CR22","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.trsl.2023.02.005","volume":"258","author":"S Cui","year":"2023","unstructured":"Cui S, Shin YJ, Fang X, Lee H, Eum SH, Ko EJ, Lim SW, Shin E, Lee KI, Lee JY et al (2023) CRISPR\/Cas9-mediated A4GALT suppression rescues Fabry disease phenotypes in a kidney organoid model. Transl Res 258:35\u201346","journal-title":"Transl Res"},{"key":"5867_CR23","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1038\/nmat4994","volume":"16","author":"NM Cruz","year":"2017","unstructured":"Cruz NM, Song X, Czerniecki SM, Gulieva RE, Churchill AJ, Kim YK, Winston K, Tran LM, Diaz MA, Fu H et al (2017) Organoid cystogenesis reveals a critical role of microenvironment in human polycystic kidney disease. Nat Mater 16:1112\u20131119","journal-title":"Nat Mater"},{"key":"5867_CR24","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead B, Salzberg SL (2012) Fast gapped-read alignment with bowtie 2. Nat Methods 9:357\u2013359","journal-title":"Nat Methods"},{"key":"5867_CR25","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1093\/bioinformatics\/btq033","volume":"26","author":"AR Quinlan","year":"2010","unstructured":"Quinlan AR, Hall IM (2010) BEDtools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26:841\u2013842","journal-title":"Bioinformatics"},{"key":"5867_CR26","doi-asserted-by":"publisher","first-page":"R80","DOI":"10.1186\/gb-2004-5-10-r80","volume":"5","author":"RC Gentleman","year":"2004","unstructured":"Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J et al (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5:R80","journal-title":"Genome Biol"},{"key":"5867_CR27","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1056\/NEJMra0902927","volume":"363","author":"BJ Nankivell","year":"2010","unstructured":"Nankivell BJ, Alexander SI (2010) Rejection of the kidney allograft. N Engl J Med 363:1451\u20131462","journal-title":"N Engl J Med"},{"key":"5867_CR28","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.coi.2004.07.011","volume":"16","author":"S Jiang","year":"2004","unstructured":"Jiang S, Herrera O, Lechler RI (2004) New spectrum of allorecognition pathways: implications for graft rejection and transplantation tolerance. Curr Opin Immunol 16:550\u2013557","journal-title":"Curr Opin Immunol"},{"key":"5867_CR29","doi-asserted-by":"publisher","first-page":"294","DOI":"10.4285\/ctr.24.0055","volume":"38","author":"H Choi","year":"2024","unstructured":"Choi H, Choi EJ, Kim HJ, Baek IC, Won A, Park SJ, Kim TG, Chung YJ (2024) A walk through the development of human leukocyte antigen typing: from serologic techniques to next-generation sequencing. Clin Transplant Res 38:294\u2013308","journal-title":"Clin Transplant Res"},{"key":"5867_CR30","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1097\/TP.0000000000001115","volume":"100","author":"RC Williams","year":"2016","unstructured":"Williams RC, Opelz G, McGarvey CJ, Weil EJ, Chakkera HA (2016) The risk of transplant failure with HLA mismatch in first adult kidney allografts from deceased donors. Transplantation 100:1094\u20131102","journal-title":"Transplantation"},{"key":"5867_CR31","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/tan.12898","volume":"88","author":"B Seliger","year":"2016","unstructured":"Seliger B (2016) Molecular mechanisms of HLA class I-mediated immune evasion of human tumors and their role in resistance to immunotherapies. HLA 88:213\u2013220","journal-title":"HLA"},{"key":"5867_CR32","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.humimm.2018.04.013","volume":"80","author":"DS Katikaneni","year":"2019","unstructured":"Katikaneni DS, Jin L (2019) B cell MHC class II signaling: a story of life and death. Hum Immunol 80:37\u201343","journal-title":"Hum Immunol"},{"key":"5867_CR33","doi-asserted-by":"publisher","first-page":"832","DOI":"10.3389\/fimmu.2017.00832","volume":"8","author":"NB Crux","year":"2017","unstructured":"Crux NB, Elahi S (2017) Human leukocyte antigen (HLA) and immune regulation: how do classical and non-classical HLA alleles modulate immune response to human immunodeficiency virus and hepatitis C virus infections? Front Immunol 8:832","journal-title":"Front Immunol"},{"key":"5867_CR34","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s40364-021-00314-8","volume":"9","author":"X Liu","year":"2021","unstructured":"Liu X, Shi Y, Zhang D, Zhou Q, Liu J, Chen M, Xu Y, Zhao J, Zhong W, Wang M (2021) Risk factors for immune-related adverse events: what have we learned and what lies ahead? Biomark Res 9:79","journal-title":"Biomark Res"},{"key":"5867_CR35","doi-asserted-by":"publisher","first-page":"200","DOI":"10.23876\/j.krcp.23.274","volume":"44","author":"HY Jung","year":"2025","unstructured":"Jung HY, Seo YJ, Hwang D, Yun WS, Kim HK, Huh S, Yoo ES, Lim JH, Choi JY, Park SH et al (2025) Safety of the reduced fixed dose of mycophenolate mofetil confirmed via therapeutic drug monitoring in de novo kidney transplant recipients. Kidney Res Clin Pract 44:200\u2013209","journal-title":"Kidney Res Clin Pract"},{"key":"5867_CR36","doi-asserted-by":"publisher","first-page":"236","DOI":"10.23876\/j.krcp.22.251","volume":"43","author":"SW Lim","year":"2024","unstructured":"Lim SW, Shin YJ, Cui S, Ko EJ, Chung BH, Yang CW (2024) Prediction of diabetes mellitus after kidney transplantation using patient-specific induced pluripotent stem cells. Kidney Res Clin Pract 43:236\u2013249","journal-title":"Kidney Res Clin Pract"},{"issue":"12","key":"5867_CR37","volume":"13","author":"L Xu","year":"2023","unstructured":"Xu L, Cai M (2023) Tacrolimus maintains the balance of neutrophil extracellular traps by inducing DNA methylation of neutrophils to reduce immune rejection. Life (Basel) 13(12):2253","journal-title":"Life (Basel)"},{"issue":"6","key":"5867_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25063189","volume":"25","author":"B Chamoun","year":"2024","unstructured":"Chamoun B, Torres IB, Gabaldon A, Jouve T, Meneghini M, Zuniga JM, Sellares J, Perello M, Seron D, Bestard O et al (2024) Expression of rejection-associated transcripts in early protocol renal transplant biopsies is associated with tacrolimus exposure and graft outcome. Int J Mol Sci 25(6):3189","journal-title":"Int J Mol Sci"},{"key":"5867_CR39","first-page":"111","volume":"25","author":"P Merville","year":"1993","unstructured":"Merville P, Pouteil-Noble C, Wijdenes J, Potaux L, Touraine JL, Banchereau J (1993) Cells infiltrating rejected human kidney allografts secrete IFN-gamma, IL-6, and IL-10, and are modulated by IL-2 and IL-4. Transplant Proc 25:111\u2013113","journal-title":"Transplant Proc"},{"key":"5867_CR40","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1097\/00007890-199608270-00020","volume":"62","author":"M Pavlakis","year":"1996","unstructured":"Pavlakis M, Strehlau J, Lipman M, Shapiro M, Maslinski W, Strom TB (1996) Intragraft IL-15 transcripts are increased in human renal allograft rejection. Transplantation 62:543\u2013545","journal-title":"Transplantation"},{"key":"5867_CR41","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1111\/j.1600-6143.2010.03053.x","volume":"10","author":"PF Halloran","year":"2010","unstructured":"Halloran PF (2010) T cell-mediated rejection of kidney transplants: a personal viewpoint. Am J Transplant 10:1126\u20131134","journal-title":"Am J Transplant"},{"key":"5867_CR42","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1097\/TP.0000000000004572","volume":"107","author":"S Short","year":"2023","unstructured":"Short S, Lewik G, Issa F (2023) An immune atlas of T cells in transplant rejection: pathways and therapeutic opportunities. Transplantation 107:2341\u20132352","journal-title":"Transplantation"},{"key":"5867_CR43","doi-asserted-by":"publisher","first-page":"630","DOI":"10.3858\/emm.2011.43.11.071","volume":"43","author":"BH Chung","year":"2011","unstructured":"Chung BH, Oh HJ, Piao SG, Sun IO, Kang SH, Choi SR, Park HS, Choi BS, Choi YJ, Park CW et al (2011) Higher infiltration by Th17 cells compared with regulatory T cells is associated with severe acute T-cell-mediated graft rejection. Exp Mol Med 43:630\u2013637","journal-title":"Exp Mol Med"},{"key":"5867_CR44","doi-asserted-by":"publisher","first-page":"5344","DOI":"10.4049\/jimmunol.0902999","volume":"184","author":"C Deteix","year":"2010","unstructured":"Deteix C, Attuil-Audenis V, Duthey A, Patey N, McGregor B, Dubois V, Caligiuri G, Graff-Dubois S, Morelon E, Thaunat O (2010) Intragraft Th17 infiltrate promotes lymphoid neogenesis and hastens clinical chronic rejection. J Immunol 184:5344\u20135351","journal-title":"J Immunol"},{"key":"5867_CR45","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.trre.2011.07.005","volume":"26","author":"LL Molinero","year":"2012","unstructured":"Molinero LL, Alegre ML (2012) Role of T cell-nuclear factor kappaB in transplantation. Transplant Rev (Orlando) 26:189\u2013200","journal-title":"Transplant Rev (Orlando)"},{"key":"5867_CR46","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/ki.2014.285","volume":"87","author":"RS Al-Lamki","year":"2015","unstructured":"Al-Lamki RS, Mayadas TN (2015) TNF receptors: signaling pathways and contribution to renal dysfunction. Kidney Int 87:281\u2013296","journal-title":"Kidney Int"},{"key":"5867_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1559494","volume":"16","author":"MA Daniels","year":"2025","unstructured":"Daniels MA, Teixeiro E (2025) The NF-kappaB signaling network in the life of T cells. Front Immunol 16:1559494","journal-title":"Front Immunol"},{"key":"5867_CR48","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/nri3834","volume":"15","author":"D Brenner","year":"2015","unstructured":"Brenner D, Blaser H, Mak TW (2015) Regulation of tumour necrosis factor signalling: live or let die. Nat Rev Immunol 15:362\u2013374","journal-title":"Nat Rev Immunol"},{"key":"5867_CR49","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1742-2094-7-16","volume":"7","author":"K Tanabe","year":"2010","unstructured":"Tanabe K, Matsushima-Nishiwaki R, Yamaguchi S, Iida H, Dohi S, Kozawa O (2010) Mechanisms of tumor necrosis factor-alpha-induced interleukin-6 synthesis in glioma cells. J Neuroinflammation 7:16","journal-title":"J Neuroinflammation"},{"key":"5867_CR50","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1002\/art.37853","volume":"65","author":"A Lee","year":"2013","unstructured":"Lee A, Qiao Y, Grigoriev G, Chen J, Park-Min KH, Park SH, Ivashkiv LB, Kalliolias GD (2013) Tumor necrosis factor alpha induces sustained signaling and a prolonged and unremitting inflammatory response in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum 65:928\u2013938","journal-title":"Arthritis Rheum"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-025-05867-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-025-05867-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-025-05867-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T11:34:51Z","timestamp":1756899291000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-025-05867-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,2]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5867"],"URL":"https:\/\/doi.org\/10.1007\/s00018-025-05867-7","relation":{},"ISSN":["1420-9071"],"issn-type":[{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,2]]},"assertion":[{"value":"31 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved the 8th of January, 2020, by Institutional Review Board of Seoul St. Mary\u2019s Hospital (KC19TISI0901). Title: \u201cDevelopment of patient tailored kidney disease research platform using kidney organoid system\u201d. All subjects provided informed consent for inclusion before they participated in this study. This study was conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors confirm their consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have not used Artificial Intelligence in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure of AI"}},{"value":"All the authors have declared no competing interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"333"}}